Because IFN-γ is deficient in the IMQ model of psoriasis, and thus incompletely recapitulates human disease, IFN-γ was injected into mice twice daily throughout the IMQ treatment protocol, and the extent of inflammation was determined. This evidence concerns the gene IFNG and psoriasis.